Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer

Journal of Nuclear Medicine

Volumn 37, Issue 2, 1996, Pages 315-320

  Van Den Abbeele, Annick D ^a   Tutrone, Ronald F ^a   Berman, Robert M ^a   Baranowska Kortylewicz, Janina ^a   Barclay, Paul D ^a   Richie, Jerome P ^a   Adelstein, S James ^a   Kassis, Amin I ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Shields Warren Radiation Laboratory   (United States)

Author keywords

5 iodo 2' deoxyuridine; Auger electron emitters; bladder cancer; radioiodine

Indexed keywords

IDOXURIDINE; METHYLNITROSOUREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTORADIOGRAPHY; BLADDER CANCER; CANCER DIAGNOSIS; CANCER STAGING; DRUG DISTRIBUTION; EARLY DIAGNOSIS; NONHUMAN; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RAT; SCINTIGRAPHY;

ANIMALS; AUTORADIOGRAPHY; CARCINOGENS; CARCINOMA, TRANSITIONAL CELL; FEMALE; IDOXURIDINE; IODINE RADIOISOTOPES; METHYLNITROSOUREA; RATS; RATS, INBRED F344; TIME FACTORS; TISSUE DISTRIBUTION; URINARY BLADDER NEOPLASMS;

EID: 0029875321     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Kantoff PW, Shipley WU, Gallagher J, Loughlin KR, Soto EA Cancer of the bladder. In: Osteen RT, ed. Cancer manual, 8th ed Boston. American Cancer Society; 1990.295-303.
2. Boring CC, Squires TS, Tong T. Cancer statistics 1993 CA Cancer J Clin 1993;43. 7-26.
3. Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP Biology and management of bladder cancer. N Engl J Med 1990,322 1129-1138.
4. Whitmore WF Jr Bladder cancer, an overview. CA Cancer J Clin 1988.38:213-223.
5. Boileau MA, Swartz D, Schmidt KL, Schmidt WA. Limitations of flow cytometric DNA analysis for the diagnosis of bladder cancer J Surg Oncol 1989,40:194-200.
6. Williams NN, Daly JM Flow cytometry and prognostic implications in patients with solid tumors Surg Gynecol Obstet 1990,171 257-266
7. Bloomer WD, Adelstein SJ Antineoplastic effect of iodine-125-labeled iododeoxyuridine. Int J Radiat Biol 1975:27 509-511.
8. 125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters Nature 1977.265:620-621.
9. 123I]iodo-2′-deoxyuridine in the radiotherapy of an early ascites tumor model Int J Radiat Oncol Biol Phys 1991;21:1541-1551
10. Kassis AI Toxicity and therapeutic effects of low-energy electrons Nucl Instrum Meth Phys Res [B] 1994.87:279-284.
11. Kassis AI, Adelstein SJ. Preclinical animal studies with radiolabeled IUdR. J Nucl Med 1996;37:343-352.
12. 125I]iodo-2′-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. Cancer Res 1990;50:5199-5203.
13. Sufrin G, Meyer JS, Martin SA, Schechtman K Proliferative activity of urothelium and tumors of renal pelvis, ureter, and urinary bladder evaluated by thymidine labeling. Urology 1984.23(suppl):15-22.
14. Hicks RM, Wakefield JSJ. Rapid induction of bladder cancer in rats with N-methyl-N-nitrosourea. I. Histology Chem Biol Interact 1972:5 139-152.
15. 123 125 127I]iodo-2′-deoxyuridine. Appl Radiat Isot 1988,39:335-341
16. Eidinoff ML, Cheong L, Rich MA. Incorporation of unnatural pyrimidine bases into deoxyribonucleic acid of mammalian cells. Science 1959;129:1550-1551
17. Morris NR, Cramer JW. DNA synthesis by mammalian cells inhibited in culture by 5-iodo-2′-deoxyuridme. Mol Pharmacol 1966,2:1-9.
18. Calabresi P, Cardoso SS, Finch SC, et al. Initial clinical studies with 5-iodo-2′-deoxyuridine. Cancer Res 1961;21:550-559.
19. Hughes WL, Commerford SL, Gitlin D, et al Deoxyribonucleic acid metabolism in vivo. I. Cell proliferation and death as measured by incorporation and elimination of iododeoxyuridine. Fed Proc 1964.23:640-648.
20. 125I after incorporation into the DNA of the mouse. Nature (London) 1965:206:949-950.
21. 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes. Radiat Res 1987,109:78-89.
22. 125I-iododeoxyuridine and azauridine Cancer Res 1963;23.1246-1259
23. Klecher RW Jr, Jenkins JF, Kinsella TJ, Fine RL, Strong JM, Collins JM Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation. Clin Pharmacol Ther 1985;38:45-51.
24. 3H: nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia. Im J Radiat Biol 1975;28:225-241.
25. 125I in mammalian cells. Radiat Res 1987;111:305-318.
26. 125I]iodo-2′-de-oxyuridine. Radiat Res 1989,118 532-544
27. Warters RL, Hofer KG, Harris CR, Smith JM. Radionuclide toxicity in cultured mammalian cells, elucidation of the primary site of radiation damage. Curr Top Radiat Res Q 1977;12:389-407
28. 131iodine. Radiat Res 1971;47:94-109.
29. Bradley EW, Chan PC, Adelstein SJ The radiotoxicity of iodine-125 in mammalian cells I Effects on the survival curve of radioiodine incorporated into DNA Radiat Res 1975;64:555-563.
30. 3HTdR Radiat Res 1976;67.332-343.
31. 125I incorporated into DNA of mammalian cells Radiat Environ Biophys 1980;18.239-248.
32. 35S: theory and application to a cellular model. Radiat Res 1980;84:407-425.
33. Kassis AI, Adelstein SJ, Haydock C, Sastry KSR, McElvany KD, Welch MJ Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells. Radiat Res 1982;90 362-373.
34. Kassis AI, Adelstein SJ, Haydock C, Sastry KSR. Thallium-201: an experimental and a theoretical radiobiological approach to dosimetry. J Nucl Med 1983,24:1164-1175.
35. Kassis AI, Sastry KSR, Adelstein SJ. Intracellular distribution and radiotoxicity of chromium-51 in mammalian cells: Auger-electron dosimetry J Nucl Med 1985;26: 59-67.
36. Kassis AI, Howell RW, Sastry KSR, Adelstein SJ. Positional effects of Auger decays in mammalian cells in culture In Baverstock KF, Charlton DE, eds. DNA damage by Auger emitters. London: Taylor & Francis, Ltd.: 1988:1-13.
37. 123I]iodo-2′-deoxyuridine in patients with inoperable liver metastases from colorectal cancer In Program and Abstracts of the Forty-second Annual Meeting of the Radiation Research Society, Nashville, TN: April 29-May 4, 1994:208.
38. Harrison K, Dalrymple GV, Baranowska-Kortylewicz J. Bladder cancer-[123I]IUdR imaging in preparation for [125I]IUdR therapy [Abstract]. J Nucl Med 1994,35 144P.
39. Herr HW, Laudone VP, Whitmore WF, Jr. An overview of intravesical therapy for superficial bladder tumors. J Urol 1987;138:1363-1368.
40. Catalona WJ, Hudson MA, Gillen DP, Andriole GL, Ratliff TL. Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for supeificial bladder cancer J Urol 1987.137 220-224.
41. Shaw GL, Mulshine JL. Biomarkers in early detection of lung cancer Contemp Oncol July/August 1991;43-51